Cubist Systematic Strategies’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-80,063
Closed -$191K 1630
2024
Q1
$191K Sell
80,063
-307,177
-79% -$734K ﹤0.01% 1680
2023
Q4
$1.29M Sell
387,240
-193,732
-33% -$645K 0.01% 992
2023
Q3
$2.17M Buy
580,972
+560,998
+2,809% +$2.1M 0.02% 755
2023
Q2
$85.3K Sell
19,974
-139,440
-87% -$595K ﹤0.01% 1838
2023
Q1
$1.09M Sell
159,414
-43,488
-21% -$297K 0.01% 1431
2022
Q4
$1.61M Sell
202,902
-21,404
-10% -$170K 0.01% 1450
2022
Q3
$2.16M Buy
224,306
+196,496
+707% +$1.89M 0.01% 1530
2022
Q2
$201K Buy
27,810
+9,036
+48% +$65.3K ﹤0.01% 3161
2022
Q1
$242K Sell
18,774
-119,358
-86% -$1.54M ﹤0.01% 2933
2021
Q4
$2.21M Buy
138,132
+118,416
+601% +$1.89M 0.02% 1278
2021
Q3
$317K Sell
19,716
-21,184
-52% -$341K ﹤0.01% 2325
2021
Q2
$566K Sell
40,900
-30,466
-43% -$422K 0.01% 1925
2021
Q1
$1.04M Buy
71,366
+60,466
+555% +$884K 0.01% 1511
2020
Q4
$189K Sell
10,900
-2,118
-16% -$36.7K ﹤0.01% 2259
2020
Q3
$239K Buy
+13,018
New +$239K ﹤0.01% 2063
2020
Q2
Sell
-112,634
Closed -$1.83M 2400
2020
Q1
$1.83M Buy
112,634
+67,193
+148% +$1.09M 0.05% 508
2019
Q4
$818K Buy
45,441
+17,603
+63% +$317K 0.02% 1287
2019
Q3
$564K Buy
27,838
+24
+0.1% +$486 0.01% 1238
2019
Q2
$615K Buy
27,814
+12,671
+84% +$280K 0.01% 1347
2019
Q1
$207K Sell
15,143
-446
-3% -$6.1K 0.01% 1755
2018
Q4
$141K Sell
15,589
-17,289
-53% -$156K 0.01% 1664
2018
Q3
$542K Buy
32,878
+9,235
+39% +$152K 0.03% 763
2018
Q2
$331K Buy
+23,643
New +$331K 0.02% 1022
2018
Q1
Sell
-11,033
Closed -$97K 1858
2017
Q4
$97K Buy
+11,033
New +$97K 0.01% 1686
2017
Q3
Sell
-12,900
Closed -$185K 1858
2017
Q2
$185K Buy
+12,900
New +$185K 0.01% 1317
2016
Q4
Sell
-5,623
Closed -$151K 1731
2016
Q3
$151K Buy
+5,623
New +$151K 0.01% 1365
2015
Q1
Sell
-14,414
Closed -$235K 1906
2014
Q4
$235K Buy
+14,414
New +$235K 0.01% 1392